tiprankstipranks
Advertisement
Advertisement

Audeara Delivers Strong Q2 Growth as Asia-Pacific Deals Drive Hearing Tech Expansion

Story Highlights
  • Audeara’s Q2 FY26 revenue surged 274% year-on-year to $1.43m, with H1 sales nearing last year’s full result and the company generating positive operating cash flow.
  • New regulatory approval in China, licensing deals with Eastech and OPTEK, and a Japanese distribution pact are accelerating Audeara’s Asia-Pacific expansion and recurring tech licensing strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Audeara Delivers Strong Q2 Growth as Asia-Pacific Deals Drive Hearing Tech Expansion

Meet Samuel – Your Personal Investing Prophet

An announcement from Audeara Ltd. ( (AU:AUA) ) is now available.

Audeara reported Q2 FY26 unaudited group revenue of $1.43 million, flat on the prior quarter but 274% higher than the same period a year earlier, supported by strong wholesale and technology licensing sales. Combined Q1 and Q2 FY26 revenues, together with a secured $560,000 purchase order to be recognised in Q3, now exceed $3.5 million, bringing the company close to its full FY25 revenue of $3.8 million, while the quarter delivered positive net operating cash flow of $356,000, boosted by a $1.22 million R&D tax refund, leaving $0.74 million in cash at bank at 31 December 2025. Operationally, momentum was underpinned by National Medical Products Administration certification in China for a hearing aid product, enabling commercial launch and a maiden licensing order from Eastech, a chip-level AI licensing deal with China-based SoC designer OPTEK Microelectronics, and a distribution agreement with Tokyo-based Eyear System to introduce Auracast-enabled products into Japan, collectively strengthening Audeara’s Asia-Pacific footprint and supporting its push toward recurring global licensing income and more consistent operational cash flow.

The most recent analyst rating on (AU:AUA) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Audeara Ltd. stock, see the AU:AUA Stock Forecast page.

More about Audeara Ltd.

Audeara Ltd is an ASX-listed hearing health technology company that generates revenue through a domestic wholesale division and its AUA Technology arm, which licenses and integrates its audio and hearing-aid technologies into products via global partners. The company focuses on audiology and hearing solutions, including Auracast-enabled products, and is expanding its presence across key Asia-Pacific markets such as China and Japan through distribution, licensing and system-on-chip partnerships.

Average Trading Volume: 528,323

Technical Sentiment Signal: Buy

Current Market Cap: A$11.4M

For a thorough assessment of AUA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1